PART I Overview Greenland Mines Ltd (the Company or Greenland Mines), formerly known as Klotho Neurosciences, Inc., develops essential medicines for the treatment of chronic diseases cancer, cardiovascular, and neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introd...
Q2 FY2026 — expected 2026-09-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-04-01 | 2025-12-31 | 0001213900-26-038629 | EDGAR | 66K words |
| 2025-03-31 | 2024-12-31 | 0001213900-25-026372 | EDGAR | — |
| 2024-04-17 | 2023-12-31 | 0001213900-24-033573 | EDGAR | — |
| 2023-04-10 | 2022-12-31 | 0001213900-23-028625 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001213900-25-109920 | EDGAR | 20K words |
| 2025-08-18 | 2025-06-30 | 0001213900-25-077684 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001213900-25-043529 | EDGAR | — |
| 2024-11-19 | 2024-09-30 | 0001213900-24-100218 | EDGAR | — |
| 2024-08-19 | 2024-06-30 | 0001213900-24-070786 | EDGAR | — |
| 2024-05-23 | 2024-03-31 | 0001213900-24-046038 | EDGAR | — |
| 2023-11-17 | 2023-09-30 | 0001213900-23-088042 | EDGAR | — |
| 2023-08-21 | 2023-06-30 | 0001213900-23-069521 | EDGAR | — |
| 2023-05-24 | 2023-03-31 | 0001213900-23-042728 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001213900-22-072415 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001213900-22-048121 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001213900-22-027170 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-23 | 0001213900-26-032870 | EDGAR | 1K words |
| 2026-03-16 | 0001213900-26-028158 | EDGAR | — |
| 2026-03-12 | 0001213900-26-026922 | EDGAR | — |
| 2026-03-10 | 0001213900-26-025750 | EDGAR | — |
| 2026-03-04 | 0001213900-26-023666 | EDGAR | — |
| 2026-03-02 | 0001213900-26-022411 | EDGAR | — |
| 2026-02-24 | 0001213900-26-019436 | EDGAR | — |
| 2026-02-17 | 0001213900-26-017490 | EDGAR | — |
| 2025-12-08 | 0001213900-25-119257 | EDGAR | — |
| 2025-09-25 | 0001213900-25-091661 | EDGAR | — |
91 total filings indexed. 65 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001907223 |
| Ticker | GRML |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Website | https://www.greenlandmines.com |
| Listed | 2026-03-12 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report